Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation

Fertility and Sterility

Volumn 93, Issue 5, 2010, Pages 1493-1499

  Hurliman, Amanda K ^a   Speroff, Leon ^a,b   Stouffer, Richard L ^a,b   Patton, Phillip E ^a   Lee, Annette ^c   Molskness, Theodore A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c IVF New Jersey   (United States)

Author keywords

angiogenesis; Angiopoietin 1; angiopoietin 2; ovarian hyperstimulation syndrome (OHSS); vascular permeability

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; GONADOTROPIN; ITURELIX; LEUPRORELIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED OVARIAN SIMULATION; CORPUS LUTEUM; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMAN; INFERTILITY THERAPY; MACACA; MENSTRUAL CYCLE; NONHUMAN; OOCYTE; OVARIECTOMY; OVARY; OVARY FOLLICLE FLUID; OVULATION; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHESUS MONKEY;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; FEMALE; FOLLICULAR FLUID; GESTATIONAL AGE; HUMANS; MACACA MULATTA; MENSTRUAL CYCLE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 77949273417     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.04.036     Document Type: Article

References (36)

1. Hazzard T.M., and Stouffer R.L. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 883-900
2. Fraser H.M., and Wulff C. Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 1 (2003) 88
3. Fraser H.M., and Duncan W.C. Vascular morphogenesis in the primate ovary. Angiogenesis 8 (2005) 101-116
4. Geva E., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
5. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
6. Hazzard T.M., Molskness T.A., Chaffin C.L., and Stouffer R.L. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 5 (1999) 1115-1121
7. Hazzard T.M., Christenson L.K., and Stouffer R.L. Changes in expression of vascular endothelial growth factor and angiopoietin -1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol Hum Reprod 6 (2000) 993-998
8. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 277 (1997) 48-50
9. Wulff C., Wilson H., Largue P., Duncan W.C., Armstrong D.G., and Fraser H.M. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, Tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab 85 (2000) 4302-4309
10. Sugino N., Suzuki T., and Sakata A. Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 90 (2005) 6141-6148
11. Tesone M., Stouffer R.L., Borman S.M., Hennebold J.D., and Molskness T.A. Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective mRNA expression in vivo and hypoxia regulated protein secretion in vitro. Biol Reprod 73 (2005) 927-934
12. Xu F., and Stouffer R.L. Local delivery of angiopoietin-2 into the preovulatory follicle terminates the menstrual cycle in rhesus monkeys. Biol Reprod 72 (2005) 1352-1358
13. Xu F., Hazzard T.M., Evans A., Charnock-Jones S., Smith S., and Stouffer R.L. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys. Contraception 71 (2005) 239-248
14. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., and Patton P.E. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod 19 (2004) 822-830
15. Artini P.G., Fasciani A., Monti M., Luisi S., D'Ambrogio G., and Genazzani A.R. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70 (1998) 560-564
16. Abramov Y., Barak V., Nisman B., and Schenker J.G. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 67 (1997) 261-265
17. Pau E., Alonso-Muriel I., and Gomez R. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Hum Reprod 21 (2006) 1453-1460
18. Neulen J., Wenzel D., Hornig C., Wunsch E., Weissenborn U., Grunwald K., et al. Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols. Hum Reprod 16 (2001) 621-626
19. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., and Patton P.E. Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation. Fertil Steril 86 (2006) 1531-1533
20. Young K.A., Chaffin C.L., Molskness T.A., and Stouffer R.L. Controlled ovulation (COv) of the dominant follicle: a critical role for LH in the late follicular phase of the menstrual cycle. Hum Reprod 18 (2003) 2257-2263
21. Duffy D.M., Chaffin C.L., and Stouffer R.L. Expression of estrogen receptor a and b in the rhesus monkey corpus luteum during the menstrual cycle: regulation by luteinizing hormone and progesterone. Endocrinology 141 (2000) 1711-1717
22. Wolf D.P., VandeVoort C.A., Meyer-Haas G.R., Zelinski-Wooten M.B., Hess D.L., Baughman W.L., et al. In vitro fertilization and embryo transfer in the rhesus monkey. Biol Reprod 41 (1989) 335-346
23. Weston A.M., Zelinski-Wooten M.B., Hutchison J.S., Stouffer R.L., and Wolf D.P. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod 11 (1996) 608-613
24. Babischkin J.S., Suresch D.L., Pepe G.J., and Albrecht E.D. Differential expression of placental villous angiopoietin-1 and -2 during early, mid and late baboon pregnancy. Placenta 28 (2007) 212-218
25. Dunk C., Shams M., Nijjar S., Rhaman M., Qiu Y., Bussolat B., et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156 (2000) 2185-2199
26. Hirokoshi K., Maeshima Y., and Kobayashi E. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia. Nephron Clin Pract 106 (2007) c43-c50
27. Loukovaara S., Immonen I., Koistinen R., Rudge J., Teramo K.A., Laatikainen L., et al. Angiopoetic factors and retinopathy in pregnancies complicated with type 1 diabetes. Diabet Med 21 (2004) 697-704
28. Albrecht E.D., Babischkin J.S., and Pepe G.J. Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy. Mol Reprod Dev 75 (2008) 504-511
29. Johnson M.L., Grazul-Bilska A.T., Redmer D.A., and Reynolds L.P. Effects of estradiol-17 beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes. Endocrine 30 (2006) 333-342
30. Demir R., Kayisli U.A., Cayli S., and Huppertz B. Sequential steps during vasculogenesis and angiogenesis in the very early human placenta. Placenta 27 (2006) 535-539
31. McClure N., Healy D.L., Rogers P.A.W., Sullivan J., Beaton L., Haning Jr. R.V., et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344 (1994) 235-236
32. Alvarez C., Marti-Bonmati L., and Novella-Maestre E. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92 (2007) 2931-2937
33. Rizk B.R.M.B. Ovarian hyperstimulation syndrome: epidemiology, pathophysiology, prevention and management (2006), Cambridge University Press, New York
34. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
35. Nag S., Papneja T., Venugopalan R., and Stewart D.J. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab Invest 85 (2005) 1189-1198
36. Mathur R.S., Akande A.V., Keay S.D., Hunt L.P., and Jenkins J.M. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 73 (2000) 901-907